aid: secretome-therapeutics
name: Secretome Therapeutics
description: >-
  Secretome Therapeutics is a clinical-stage biotechnology company (formerly NeoProgen, founded 2018)
  developing allogeneic, off-the-shelf regenerative therapies derived from neonatal cardiac progenitor
  cells (nCPCs). Its lead candidate STM-01, and the cell-free secretome STM-2, target heart failure with
  preserved ejection fraction (HFpEF), dilated cardiomyopathy (DCM) and Duchenne muscular dystrophy
  associated cardiomyopathy, and are in Phase 1 clinical study. The company publishes a corporate and
  investor-relations website covering its science, pipeline, team, patient/expanded-access policy and
  press releases; it publishes no developer program, API, SDK or machine-readable contract of any kind.
url: https://raw.githubusercontent.com/api-evangelist/secretome-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Therapeutics
- Regenerative Medicine
- Cell Therapy
- Cardiology
- Clinical Stage
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
image: https://storage.googleapis.com/vendorgroup-assets/site/c26b1537-b667-48ad-bd88-c03a4a03b51d/2026/03/20/69bc8e242fbd420ce21e43d1/secretome-social.jpg
common:
- type: DomainSecurity
  url: security/secretome-therapeutics-domain-security.yml
- type: Website
  url: https://secretometherapeutics.com/
- type: TermsOfService
  url: https://secretometherapeutics.com/terms
- type: PrivacyPolicy
  url: https://secretometherapeutics.com/privacy-policy
- type: News
  url: https://secretometherapeutics.com/news-publications
- type: PressReleases
  url: https://secretometherapeutics.com/press-releases
- type: Team
  url: https://secretometherapeutics.com/team
- type: Contact
  url: https://secretometherapeutics.com/contact
- type: SecondaryMarketListing
  url: https://forgeglobal.com/secretome-therapeutics_stock/
- type: LLMsTxt
  url: llms/secretome-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Secretome Therapeutics is a clinical-stage cell-therapy developer whose only web property is a
    VendorGroup/Kscope investor-relations site with seven marketing pages and no developer section;
    that platform answers HTTP 200 with the homepage HTML for every unknown path, so /openapi.json,
    /graphql, /llms.txt and all seven /.well-known/ probes returned soft-404 HTML shells rather than
    documents, and no GitHub organisation, npm or PyPI package exists under the company name.
  evidence:
  - url: https://secretometherapeutics.com/openapi.json
    status: 200
  - url: https://secretometherapeutics.com/.well-known/agent-card.json
    status: 200
  - url: https://secretometherapeutics.com/.well-known/security.txt
    status: 200
  - url: https://api.github.com/orgs/secretome-therapeutics
    status: 404
  - url: https://secretometherapeutics.com/our-science
    status: 200
  checked: '2026-08-26'